IBDEI1PE ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28509,1,4,0)
 ;;=4^R63.0
 ;;^UTILITY(U,$J,358.3,28509,2)
 ;;=^7939
 ;;^UTILITY(U,$J,358.3,28510,0)
 ;;=R63.1^^132^1332^138
 ;;^UTILITY(U,$J,358.3,28510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28510,1,3,0)
 ;;=3^Polydipsia
 ;;^UTILITY(U,$J,358.3,28510,1,4,0)
 ;;=4^R63.1
 ;;^UTILITY(U,$J,358.3,28510,2)
 ;;=^186699
 ;;^UTILITY(U,$J,358.3,28511,0)
 ;;=R63.2^^132^1332^139
 ;;^UTILITY(U,$J,358.3,28511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28511,1,3,0)
 ;;=3^Polyphagia
 ;;^UTILITY(U,$J,358.3,28511,1,4,0)
 ;;=4^R63.2
 ;;^UTILITY(U,$J,358.3,28511,2)
 ;;=^5019540
 ;;^UTILITY(U,$J,358.3,28512,0)
 ;;=R63.3^^132^1332^72
 ;;^UTILITY(U,$J,358.3,28512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28512,1,3,0)
 ;;=3^Feeding Difficulties
 ;;^UTILITY(U,$J,358.3,28512,1,4,0)
 ;;=4^R63.3
 ;;^UTILITY(U,$J,358.3,28512,2)
 ;;=^5019541
 ;;^UTILITY(U,$J,358.3,28513,0)
 ;;=R63.4^^132^1332^29
 ;;^UTILITY(U,$J,358.3,28513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28513,1,3,0)
 ;;=3^Abnormal Weight Loss
 ;;^UTILITY(U,$J,358.3,28513,1,4,0)
 ;;=4^R63.4
 ;;^UTILITY(U,$J,358.3,28513,2)
 ;;=^5019542
 ;;^UTILITY(U,$J,358.3,28514,0)
 ;;=R63.5^^132^1332^28
 ;;^UTILITY(U,$J,358.3,28514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28514,1,3,0)
 ;;=3^Abnormal Weight Gain
 ;;^UTILITY(U,$J,358.3,28514,1,4,0)
 ;;=4^R63.5
 ;;^UTILITY(U,$J,358.3,28514,2)
 ;;=^5019543
 ;;^UTILITY(U,$J,358.3,28515,0)
 ;;=R64.^^132^1332^46
 ;;^UTILITY(U,$J,358.3,28515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28515,1,3,0)
 ;;=3^Cachexia
 ;;^UTILITY(U,$J,358.3,28515,1,4,0)
 ;;=4^R64.
 ;;^UTILITY(U,$J,358.3,28515,2)
 ;;=^17920
 ;;^UTILITY(U,$J,358.3,28516,0)
 ;;=R68.3^^132^1332^51
 ;;^UTILITY(U,$J,358.3,28516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28516,1,3,0)
 ;;=3^Clubbing of Fingers
 ;;^UTILITY(U,$J,358.3,28516,1,4,0)
 ;;=4^R68.3
 ;;^UTILITY(U,$J,358.3,28516,2)
 ;;=^5019553
 ;;^UTILITY(U,$J,358.3,28517,0)
 ;;=R73.01^^132^1332^89
 ;;^UTILITY(U,$J,358.3,28517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28517,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,28517,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,28517,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,28518,0)
 ;;=R73.02^^132^1332^90
 ;;^UTILITY(U,$J,358.3,28518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28518,1,3,0)
 ;;=3^Impaired Glucose Tolerance (oral)
 ;;^UTILITY(U,$J,358.3,28518,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,28518,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,28519,0)
 ;;=R73.09^^132^1332^15
 ;;^UTILITY(U,$J,358.3,28519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28519,1,3,0)
 ;;=3^Abnormal Glucose NEC
 ;;^UTILITY(U,$J,358.3,28519,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,28519,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,28520,0)
 ;;=R73.9^^132^1332^84
 ;;^UTILITY(U,$J,358.3,28520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28520,1,3,0)
 ;;=3^Hyperglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,28520,1,4,0)
 ;;=4^R73.9
 ;;^UTILITY(U,$J,358.3,28520,2)
 ;;=^5019564
 ;;^UTILITY(U,$J,358.3,28521,0)
 ;;=R76.11^^132^1332^142
 ;;^UTILITY(U,$J,358.3,28521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28521,1,3,0)
 ;;=3^Positive PPD
 ;;^UTILITY(U,$J,358.3,28521,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,28521,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,28522,0)
 ;;=R79.1^^132^1332^3
 ;;^UTILITY(U,$J,358.3,28522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28522,1,3,0)
 ;;=3^Abnormal Coagulation Profile
 ;;^UTILITY(U,$J,358.3,28522,1,4,0)
 ;;=4^R79.1
 ;;^UTILITY(U,$J,358.3,28522,2)
 ;;=^5019591
 ;;^UTILITY(U,$J,358.3,28523,0)
 ;;=R82.5^^132^1332^69
 ;;^UTILITY(U,$J,358.3,28523,1,0)
 ;;=^358.31IA^4^2
